(Q48711070)

14 February 2018

title

Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome (English)

1 reference

14 February 2018

0 references

1

1 reference

14 February 2018

author name string

Majeed T

2

1 reference

14 February 2018

Lavelle E

3

1 reference

14 February 2018

Scott LV

4

1 reference

14 February 2018

Berti C

5

1 reference

14 February 2018

Behan P

6

1 reference

14 February 2018

publication date

1 May 1997

1 reference

14 February 2018

published in

Psychoneuroendocrinology

1 reference

14 February 2018

volume

22

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

page(s)

261-267

1 reference

14 February 2018

The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

A specific, non-chromatographic radioimmunoassay for human plasma cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Selective control by corticosterone of serotonin1 receptor capacity in raphe-hippocampal system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Glucocorticoids and the genesis of depressive illness. A psychobiological model

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Chronic fatigue syndrome: a working case definition.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2897%2900002-4

7 January 2021

10.1016/S0306-4530(97)00002-4

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018